MedPath

Redox Status and Immune Function

Not Applicable
Completed
Conditions
Aseptic Inflammation
Skeletal Muscle Function
Skeletal Muscle Damage
Interventions
Dietary Supplement: n-acetylcysteine
Dietary Supplement: Placebo
Registration Number
NCT02930031
Lead Sponsor
National and Kapodistrian University of Athens
Brief Summary

In this investigation the investigators utilized N-acetylcysteine (NAC) supplementation to enhance reduced glutathione (GSH) stores during an 8-day recovery period from a strenuous eccentric exercise protocol in order to test the hypotheses: i) redox status perturbations in skeletal muscle are pivotal for the immune responses and ii) antioxidant supplementation may alter immune cell responses following exercise-induced muscle microtrauma.

Detailed Description

The major thiol-disulfide couple of GSH and oxidized glutathione (GSSG) is a crucial regulator of the main transcriptional pathways regulating aseptic inflammation and recovery of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper exercise-induced inflammatory responses.

The objective was to examine how thiol-based antioxidant supplementation affects immune mobilization following exercise-induced skeletal muscle microtrauma. In a two-trial, double-blind, crossover, repeated measures design, 10 young men received either placebo or NAC (20 mg/kg/day) immediately after a muscle-damaging exercise protocol (300 eccentric contractions) and for eight consecutive days. Blood sampling and performance assessment were performed pre-exercise, 2h post-exercise and daily for 8 consecutive days.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
10
Inclusion Criteria
  • Recreationally trained (VO2max > 45 ml/kg/min)
  • Engaged in regular exercise for ≥3 times/week for > 12 months
  • non-smokers
  • Abstain from exercise during the course of the two trials
  • No consumption of performance-enhancing substances, antioxidants, caffeine, alcohol and/or medications during the study.
Exclusion Criteria
  • NAC intolerance
  • Recent musculoskeletal injuries of the lower limbs
  • Febrile illness
  • History of muscle lesion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
n-acetylcysteinen-acetylcysteineorally in three daily dosages, at 20 mg/kg/day, daily for eight days after exercise
PlaceboPlaceboorally in three daily dosages, content: 500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder
Primary Outcome Measures
NameTimeMethod
Changes in protein carbonyls in red blood cellsPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Concentration of protein carbonyls

Changes in total antioxidant capacity in serumPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in oxidized glutathione in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Concentration of oxidized glutathione in red blood cells

Changes in creatine kinase activity in serumPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in lymphocyte count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of lymphocyte count in blood

Changes in thiobarbituric acid reactive substances in red blood cellsPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Thiobarbituric acid reactive substances concentration in red blood cells

Changes in reduced glutathione in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Concentration of reduced glutathione in red blood cells

Changes in high sensitivity C-reactive protein in serumPre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
Changes in catalase activity in red blood cellsPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in HLA+/Macr+ macrophage count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of HLA+/Macr+ count in blood

Changes in natural killer (NK) cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of natural killer cell count in blood

Changes in adhesion molecule concentration in bloodPre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise

Measurement of soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular cell adhesion molecule-1 (sICAM-1) concentrations in plasma

Changes in neutrophil count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of neutrophil count in blood

Changes in basophil count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of baseophil count in blood

Changes in eosinophil count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of eosinophil count in blood

Changes in T cytotoxic cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of T cytotoxic cell count in blood

Changes in white blood cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in cytokine concentration in serumPre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise, 8 days post-exercise

Measurement of interleukin-1β (IL-1β) and interleukin-6 (IL-6)

Changes in T-helper cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of T-helper cell count in blood

Changes in natural killer-T (NK-T) cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of NK-T cell count in blood

Changes in monocyte count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of monocyte count in blood

Changes in B lympho cell count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of B lympho cell count in blood

Changes in macrophage count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of macrophage count in blood

Changes in 62L macrophage count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of 62L macrophage count in blood

Changes in 11B+ macrophage count in bloodPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Cytofluorometric analysis of 11B+ macrophage count in blood

Secondary Outcome Measures
NameTimeMethod
Changes in muscle performancePre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Assessment of maximal knee extensor eccentric peak torque on an isokinetic dynamometer at 60o/s.

Changes in delayed onset of muscle sorenessPre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Assessment of the delayed onset of muscle soreness by palpation of the vastus lateralis and rectus femoris following a squat motion

Maximal aerobic capacityOne day before exercise

Assessment of maximal oxygen consumption

Body compositionOne day before exercise

Measurement of body composition by Dual Emission X-ray Absorptiometry (DXA)

Changes in dietary intake profileOne day before exercise and daily for 8 consecutive days post-exercise

Assessment of dietary intake with emphasis on antioxidant element intake

Trial Locations

Locations (1)

University of Athens, Medical School, Department of Clinical Therapeutics

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath